General Information of DTT (ID: TTKBM7V)

DTT Name ATM serine/threonine kinase (ATM) DTT Info
Gene Name ATM

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
4 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZD0156 DMWCJEU Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
AZD1390 DMYBX4N Recurrent glioblastoma 2A00.00 Phase 1 [1]
M3541 DMG98QO Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
KU-60019 DMWA5XP Non-small-cell lung cancer 2C25.Y Clinical trial [2]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
CGK733 DM8OAN9 Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther. 2009 Oct;8(10):2894-902.
3 Small molecule-based reversible reprogramming of cellular lifespan. Nat Chem Biol. 2006 Jul;2(7):369-74.